Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Summary

Purpose of the study is to evaluate the effectiveness and safety of a new investigational dur, IC351. Study is designed to gather information regarding the possible usefulness of IC351 as a treatment of several blood vessel features of scleroderma. This includes Raynaud phenomenon as well as the vaginal dryness and discomfort associated with scleroderma

Timeline

Start

2001-07

Primary completion

2002-07

Completion

2002-07

Drugs

Indications